Back
Compare AU
Compare KSM vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are KSM and DRUG. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.
Community Stats
KSM | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 1 | 67 |
Median incremental investment | $1,004.26 | $738.73 |
Median investment frequency | Monthly | Monthly |
Median total investment | $956.48 | $1,951.68 |
Average age group | 26 - 35 | > 35 |
Key Summary
KSM | DRUG | |
|---|---|---|
Strategy | KSM.AX was created on 2013-12-01 by K2. The fund's investment portfolio concentrates primarily on small cap equity. The Fund aims to deliver capital growth over the Long-Term by seeking out opportunities in undervalued companies in all market cycles | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | K2 Australian Small Cap Hedge Fund - Complex ETF (100 %) | BRL - BRAZILIAN REAL (0 %) AUD - AUSTRALIA DOLLAR (0 %) CHF - SWISS FRANC (0 %) |
Top 3 industries | Other (75.91 %) Communication Services (33.53 %) Health Care (23.80 %) | |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | |
Management fee | 1.31 % | 0.57 % |
Key Summary
KSM | DRUG | |
|---|---|---|
Issuer | K2 | BetaShares |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | |
Asset class | ETF | ETF |
Management fee | 1.31 % | 0.57 % |
Price | $2.44 | $8.49 |
Size | $11.369 million | $168.713 million |
10Y return | N/A | N/A |
Annual dividend/ distribution yield (5Y) | 0.42 % | 1.97 % |
Market | ASX | ASX |
First listed date | 15/12/2015 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
KSM | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 1 | 67 |
Median incremental investment | $1,004.26 | $738.73 |
Median investment frequency | Monthly | Monthly |
Median total investment | $956.48 | $1,951.68 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
KSM | DRUG | |
|---|---|---|
Pros |
| |
Cons |
|
KSM | DRUG |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |